CAH vs COR
As of Sep 20, 2026, Cardinal Health (CAH) scores 6.6/10 and Cencora (COR) 5.0/10 on AlphaStocks' five-model composite, so CAH scores higher. CAH trades 50% above its model fair value; COR trades 57% above its model fair value.
CAH
CARDINAL HEALTH INC
6.6
Consider Buy
$225.33
COR
Cencora, Inc.
5.0
Consider Buy
$308.61
CAH vs COR: Which is the Better Investment?
CARDINAL HEALTH INC (CAH) scores 6.6/10 while Cencora, Inc. (COR) scores 5.0/10 on AlphaStocks' composite model. CARDINAL HEALTH INC has the higher composite rating of Consider Buy. On a P/E basis, CARDINAL HEALTH INC trades at 34.9x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | CAH | COR |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.6/10▲ | 5.0/10 |
| Rating | Consider Buy▲ | Consider Buy |
| Price | $225.33 | $308.61 |
| P/E Ratio | 34.9▲ | 38.8 |
| ROE | -54.5% | 89.1%▲ |
| Market Cap | $53B | $60B |
| Fair Value | $149.86 | $197.12 |
| Dividend Yield | 0.9%▲ | 0.7% |
| Sector Rank | #24 of 168▲ | #113 of 168 |
| Model Verdicts | ||
| Piotroski | Attractive | Attractive |
| Buffett | Attractive | Strong▲ |
| Graham | Neutral▲ | Caution |
| Lynch | Strong▲ | Neutral |
| Greenblatt | Neutral▲ | Caution |
Related comparisons
CAH vs COR: Which Stock Scores Higher?
CARDINAL HEALTH INC (CAH) and Cencora, Inc. (COR) are both in the Health Care sector. CAH currently leads with a composite score of 6.6/10 (Consider Buy) compared to COR's 5.0/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer